473 related articles for article (PubMed ID: 29904899)
1. Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.
Emmi G; Urban ML; Imazio M; Gattorno M; Maestroni S; Lopalco G; Cantarini L; Prisco D; Brucato A
Curr Cardiol Rep; 2018 Jun; 20(8):61. PubMed ID: 29904899
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Interleukin-1 in the Treatment of Selected Cardiovascular Complications.
Heydari FS; Zare S; Roohbakhsh A
Curr Rev Clin Exp Pharmacol; 2021; 16(3):219-227. PubMed ID: 32674739
[TBL] [Abstract][Full Text] [Related]
3. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
[TBL] [Abstract][Full Text] [Related]
4. Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.
Tomelleri A; Cavalli G; De Luca G; Campochiaro C; D'Aliberti T; Tresoldi M; Dagna L
Front Immunol; 2018; 9():1233. PubMed ID: 29910817
[TBL] [Abstract][Full Text] [Related]
5. Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events.
Abbate A; Van Tassell BW; Biondi-Zoccai GG
BioDrugs; 2012 Aug; 26(4):217-33. PubMed ID: 22571369
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 blockade for the treatment of pericarditis.
Buckley LF; Viscusi MM; Van Tassell BW; Abbate A
Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):46-53. PubMed ID: 28633474
[TBL] [Abstract][Full Text] [Related]
7. Paradigm Shift in Diagnosis and Targeted Therapy in Recurrent Pericarditis.
Dong T; Klein AL; Wang TKM
Curr Cardiol Rep; 2023 Sep; 25(9):993-1000. PubMed ID: 37458866
[TBL] [Abstract][Full Text] [Related]
8. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside.
Buckley LF; Abbate A
BioDrugs; 2018 Apr; 32(2):111-118. PubMed ID: 29549570
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
[TBL] [Abstract][Full Text] [Related]
11. Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents.
Biondi-Zoccai G; Garmendia CM; Abbate A; Giordano A; Frati G; Sciarretta S; Antonazzo B; Versaci F
Curr Atheroscler Rep; 2020 Jan; 22(1):4. PubMed ID: 31932973
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 blockade in cardiovascular diseases: a clinical update.
Buckley LF; Abbate A
Eur Heart J; 2018 Jun; 39(22):2063-2069. PubMed ID: 29584915
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments.
Bizzi E; Trotta L; Pancrazi M; Nivuori M; Giosia V; Matteucci L; Montori D; Brucato A
Curr Cardiol Rep; 2021 Jul; 23(9):128. PubMed ID: 34319478
[TBL] [Abstract][Full Text] [Related]
14. Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab.
Epçaçan S; Sahin S; Kasapcopur O
Cardiol Young; 2019 Apr; 29(4):549-551. PubMed ID: 30931868
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 blockade treatment decreasing cardiovascular risk.
Zheng ZH; Zeng X; Nie XY; Cheng YJ; Liu J; Lin XX; Yao H; Ji CC; Chen XM; Jun F; Wu SH
Clin Cardiol; 2019 Oct; 42(10):942-951. PubMed ID: 31415103
[TBL] [Abstract][Full Text] [Related]
16. Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
Imazio M; Lazaros G; Gattorno M; LeWinter M; Abbate A; Brucato A; Klein A
Eur Heart J; 2022 Aug; 43(31):2946-2957. PubMed ID: 34528670
[TBL] [Abstract][Full Text] [Related]
17. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
Brucato A; Emmi G; Cantarini L; Di Lenarda A; Gattorno M; Lopalco G; Marcolongo R; Imazio M; Martini A; Prisco D
Intern Emerg Med; 2018 Jun; 13(4):475-489. PubMed ID: 29633070
[TBL] [Abstract][Full Text] [Related]
18. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.
Dinarello CA; Simon A; van der Meer JW
Nat Rev Drug Discov; 2012 Aug; 11(8):633-52. PubMed ID: 22850787
[TBL] [Abstract][Full Text] [Related]
19. Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020.
Tombetti E; Mulè A; Tamanini S; Matteucci L; Negro E; Brucato A; Carnovale C
Curr Cardiol Rep; 2020 Jun; 22(8):59. PubMed ID: 32562029
[TBL] [Abstract][Full Text] [Related]
20. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.
Cavalli G; Dinarello CA
Rheumatology (Oxford); 2015 Dec; 54(12):2134-44. PubMed ID: 26209330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
